Atlas Trials

A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants

Clinical trial NCT03467984 · COMPLETED

Trial details

NCT number
NCT03467984
Sponsor
LG Chem
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pneumococcal Infection
Start date
2018-05-25
Primary completion
2018-10-05
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.